---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-104019"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T19:42:10.581388+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AVITA Medical appoints Michael Tarnoff to Board; Cary Vance becomes Board Chair

## Summary
- Dr. Michael Tarnoff appointed as non-executive Director, effective August 6, 2025; most recently Chief Physician Executive and CEO at Tufts Medical Center.
- Tarnoff receives $70,000 annual cash retainer, initial equity grant of $210,000 (30% options, 70% RSUs); annual grants subject to shareholder approval.
- Cary Vance elected Board Chair, succeeding Lou Panaccio after more than 10 years of service; effective August 7, 2025.

## SEC filing metadata
- accession: 0000950170-25-104019
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000095017025104019/0000950170-25-104019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000095017025104019/rcel-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-104019
- JSON: https://secwatch.observer/filing/0000950170-25-104019.json
- Plain text: https://secwatch.observer/filing/0000950170-25-104019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.